Achieving optimal results with tirzepatide requires a holistic approach which incorporates dietary mindfulness, tailored physical activities, suitable sleep routines, and continued provider engagement
GLP-1 and GLP-1/GIP products currently licensed for weight loss in the UKSaxenda (liraglutide), Wegovy (semaglutide), and Mounjaro (tirzepatide)are licensed by the Medicines and Healthcare products Regulatory Agency for patients who (i) have obesity (body mass index [BMI] 30 kg/m 2 ) or (ii) have a BMI in the overweight range (BMI 27 kg/m 2 ) plus weight-related comorbidities, such as cardiovascular disease [12]
These compounds have been reported to be effective at suppressing oxidative stress and inflammation both in vitro and in animal models (Day 2004)
Gastroenterology Medications for digestive health and GI conditions
Tirzepatide may lead to faster results and improved blood sugar control, especially for clients with insulin resistance, but may be more expensive
Direct contact with dermal fibroblasts means higher local concentration where you want it